Search Medical Condition
Please enter condition
Please choose location

Hearing Loss Clinical Trials

A listing of Hearing Loss medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (44) clinical trials

Examining the efficacy and safety trial of AM-111 (a gel that is injected), in the the treatment of subjects suffering from sudden hearing loss. This research study may be an option for you. Please see the eligibility criteria to see if you may qualify. Please reach out to our research ...

Phase

This is a Phase III, randomized, double-blind, placebo-controlled, parallel group, multicenter, efficacy and safety trial of AM-111 in the the treatment of subjects suffering from idiopathic sudden sensorineural hearing loss.

Phase

A Clinical Trial seeking patients for a research study for the treatment of Hair Disease.

Phase N/A

Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment

This is a Phase III, randomized, double-blind, placebo-controlled, parallel group, multi-center, efficacy and safety trial of AM-111 in the treatment of subjects suffering from severe to profound idiopathic sudden sensorineural hearing loss. The active pharmaceutical ingredient of AM-111 is a JNK inhibitor (D-JNKI-1), a synthetic peptide consisting of 31 D-amino ...

Phase

Benefits of the HiResolution Bionic Ear System in Adults With Asymmetric Hearing Loss

The purpose of this feasibility study is to evaluate the benefit of unilateral implantation in adults who meet conventional indications for implantation in one ear, but do not meet the conventional indications for implantation in the other ear (asymmetric hearing loss) using the HiResolution Bionic Ear System.

Phase N/A

Rilonacept for Treatment of Autoimmune Neurosensory Hearing Loss

Ten (10) patients in total will be enrolled in this study at Metroplex Clinical Research Center in Dallas, TX. Patients may be identified and referred by local area audiologist. The ANSHL study population will be defined by inclusion and exclusion criteria designed to limit enrollment to individuals with idiopathic, progressive, ...

Phase N/A

Intracochlear Potentials: Volta Study

The clinical investigation will gather impedance and transimpedance (voltage tomography) data intraoperatively and post-operatively which can be used to characterize the electrical properties of the living cochlea. The Surgical Assistant Research Tool (SA16) research software is a software tool developed by Cochlear Limited. The use of the SA16 research software ...

Phase N/A

Cochlear Implant Low Power Strategy

Reducing power consumption in the cochlear implant is crucial to the development of future smaller sound processors. The commercial MP3000 sound coding strategy has been shown to be more efficient in power consumption to the standard ACE strategy. However in order to develop smaller sound processors, further battery life power ...

Phase N/A

Quest Sound Recover (SR2) vs. Venture SR2

Goal of this study is to determine the benefit of an improved feature on a new hearing aid platform. To investigate the improvements of this feature is compared on a new and older hearing aid platform. The obtained results will be used for future improvement for this feature. This feature ...

Phase N/A

Cochlear Implant With Anti-Inflammatory Agent

In an effort to further preserve residual acoustic hearing after cochlear implantation, it may be beneficial to incorporate anti-inflammatory agents into the electrode array for passive elution over a time course after implantation. This study aims to assess the ease and effectiveness of such an electrode design, and to assess ...

Phase N/A